{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/667112200",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/873941688"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#667112200",
  "code": "XM8NQ0",
  "source": "http://id.who.int/icd/entity/667112200",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Comirnaty®"
  },
  "definition": {
    "@language": "en",
    "@value": "A nucleoside-modified messenger RNA (modified nucleosides or by synthetic nucleoside analogues)."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Comirnaty®"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Tozinameran"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Pfizer–BioNTech COVID-19 vaccine BNT162b2"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "3 LNP-mRNAS"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Tozinameran (INN)"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "BNT162b2/COMIRNATY"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Pfizer BioNTech - Comirnaty"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "BNT162"
      }
    }
  ]
}